0001104659-21-023079.txt : 20210216
0001104659-21-023079.hdr.sgml : 20210216
20210216084649
ACCESSION NUMBER: 0001104659-21-023079
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201231
FILED AS OF DATE: 20210216
DATE AS OF CHANGE: 20210216
EFFECTIVENESS DATE: 20210216
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foresite Capital Management III, LLC
CENTRAL INDEX KEY: 0001645157
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-17183
FILM NUMBER: 21632947
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001645157
XXXXXXXX
12-31-2020
12-31-2020
false
Foresite Capital Management III, LLC
600 Montgomery Street
Suite 4500
San Francisco
CA
94111
13F HOLDINGS REPORT
028-17183
N
James B. Tananbaum
Managing Member
415-877-4887
/s/ James B. Tananbaum
San Francisco
CA
02-16-2021
0
8
86035
INFORMATION TABLE
2
infotable.xml
Acceleron Pharma Inc.
COM
00434H108
13898
108630
SH
SOLE
108630
0
0
Aclaris Therapeutics, Inc.
COM
00461U105
10483
1620244
SH
SOLE
1620244
0
0
Cymabay Therapeutics, Inc.
COM
23257D103
9424
1641804
SH
SOLE
1641804
0
0
Epizyme, Inc.
COM
29428V104
10841
998278
SH
SOLE
998278
0
0
FibroGen, Inc.
COM
31572Q808
11342
305784
SH
SOLE
305784
0
0
Natera, Inc.
COM
632307104
12669
127305
SH
SOLE
127305
0
0
Novavax, Inc.
COM
670002401
558
5000
SH
SOLE
5000
0
0
Oric Pharmaceuticals, Inc.
COM
06822P109
16820
496893
SH
SOLE
496893
0
0